// STATE LEGISLATION TRACKER

Mississippi HB 1430: Prescription drugs; prohibit licensing boards from prohibiting practitioners from prescribing for off-label use.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Mississippi
Bill: HB 1430
Session: 2026
Filed: 2025-01-20
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Mississippi HB1430 would have made possession of less than 3.5 ounces of marijuana subject to a civil penalty instead of the current criminal penalty framework. It does not appear to address compounded peptides, prescribing, telehealth, clinician scope, FDA 503A/503B compounding, or prescription monitoring, so it has no direct peptide-ecosystem impact.

Key Points

No direct change to peptide access or prescribing
No changes to compounding pharmacy rules
No telehealth or NP/naturopath scope changes
Applies to marijuana possession penalties, not peptides
Controlled-substance changes appear cannabis-specific

What to Watch For

Note Future cannabis penalty bills may still be irrelevant to peptides unless they change broader controlled-substance rules.

Note Peptide users should not treat this as changing access to compounded or off-label peptides.

Note Clinicians do not appear to gain or lose prescribing authority under this bill.

Where the Bill Stands

The bill died in committee on February 3, 2026, so it did not advance in the Mississippi Legislature.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws